nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—chronic obstructive pulmonary disease	0.315	1	CbGaD
Pitavastatin—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.227	0.476	CbGbCtD
Pitavastatin—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0497	0.104	CbGbCtD
Pitavastatin—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0457	0.0959	CbGbCtD
Pitavastatin—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0457	0.0959	CbGbCtD
Pitavastatin—ALB—Prednisone—chronic obstructive pulmonary disease	0.0356	0.0747	CbGbCtD
Pitavastatin—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0346	0.0727	CbGbCtD
Pitavastatin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0197	0.0414	CbGbCtD
Pitavastatin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0186	0.0391	CbGbCtD
Pitavastatin—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00264	0.0202	CcSEcCtD
Pitavastatin—Cognitive impairment—Prednisone—chronic obstructive pulmonary disease	0.00257	0.0197	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Aminophylline—chronic obstructive pulmonary disease	0.00253	0.0194	CcSEcCtD
Pitavastatin—Memory loss—Prednisone—chronic obstructive pulmonary disease	0.00228	0.0175	CcSEcCtD
Pitavastatin—Memory impairment—Montelukast—chronic obstructive pulmonary disease	0.00213	0.0163	CcSEcCtD
Pitavastatin—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.0161	CcSEcCtD
Pitavastatin—Fluvastatin—CYP1A1—chronic obstructive pulmonary disease	0.00156	0.377	CrCbGaD
Pitavastatin—Cognitive disorder—Prednisone—chronic obstructive pulmonary disease	0.00155	0.0119	CcSEcCtD
Pitavastatin—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.0117	CcSEcCtD
Pitavastatin—Fluvastatin—CYP1A2—chronic obstructive pulmonary disease	0.00151	0.363	CrCbGaD
Pitavastatin—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.0109	CcSEcCtD
Pitavastatin—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.0108	CcSEcCtD
Pitavastatin—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.0104	CcSEcCtD
Pitavastatin—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.0101	CcSEcCtD
Pitavastatin—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.00132	0.0101	CcSEcCtD
Pitavastatin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00957	CcSEcCtD
Pitavastatin—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00946	CcSEcCtD
Pitavastatin—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00847	CcSEcCtD
Pitavastatin—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00847	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00836	CcSEcCtD
Pitavastatin—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00108	0.0083	CcSEcCtD
Pitavastatin—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.0083	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—chronic obstructive pulmonary disease	0.00108	0.26	CrCbGaD
Pitavastatin—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00819	CcSEcCtD
Pitavastatin—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00819	CcSEcCtD
Pitavastatin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00808	CcSEcCtD
Pitavastatin—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00802	CcSEcCtD
Pitavastatin—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.008	CcSEcCtD
Pitavastatin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00791	CcSEcCtD
Pitavastatin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00785	CcSEcCtD
Pitavastatin—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00773	CcSEcCtD
Pitavastatin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000987	0.00756	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00098	0.0075	CcSEcCtD
Pitavastatin—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.000956	0.00732	CcSEcCtD
Pitavastatin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000952	0.00729	CcSEcCtD
Pitavastatin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000947	0.00725	CcSEcCtD
Pitavastatin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00091	0.00697	CcSEcCtD
Pitavastatin—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000893	0.00684	CcSEcCtD
Pitavastatin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000883	0.00676	CcSEcCtD
Pitavastatin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000877	0.00672	CcSEcCtD
Pitavastatin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000859	0.00658	CcSEcCtD
Pitavastatin—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.000854	0.00654	CcSEcCtD
Pitavastatin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000838	0.00642	CcSEcCtD
Pitavastatin—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000834	0.00639	CcSEcCtD
Pitavastatin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.00628	CcSEcCtD
Pitavastatin—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000804	0.00616	CcSEcCtD
Pitavastatin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000792	0.00607	CcSEcCtD
Pitavastatin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000786	0.00602	CcSEcCtD
Pitavastatin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000786	0.00602	CcSEcCtD
Pitavastatin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000755	0.00578	CcSEcCtD
Pitavastatin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000755	0.00578	CcSEcCtD
Pitavastatin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00075	0.00575	CcSEcCtD
Pitavastatin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000723	0.00553	CcSEcCtD
Pitavastatin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00552	CcSEcCtD
Pitavastatin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00552	CcSEcCtD
Pitavastatin—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000716	0.00548	CcSEcCtD
Pitavastatin—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000716	0.00548	CcSEcCtD
Pitavastatin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.00545	CcSEcCtD
Pitavastatin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000703	0.00539	CcSEcCtD
Pitavastatin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000702	0.00537	CcSEcCtD
Pitavastatin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000691	0.00529	CcSEcCtD
Pitavastatin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000691	0.00529	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000686	0.00526	CcSEcCtD
Pitavastatin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000681	0.00522	CcSEcCtD
Pitavastatin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00068	0.00521	CcSEcCtD
Pitavastatin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000676	0.00518	CcSEcCtD
Pitavastatin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000672	0.00514	CcSEcCtD
Pitavastatin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000672	0.00514	CcSEcCtD
Pitavastatin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00508	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000653	0.005	CcSEcCtD
Pitavastatin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.005	CcSEcCtD
Pitavastatin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000644	0.00493	CcSEcCtD
Pitavastatin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000635	0.00486	CcSEcCtD
Pitavastatin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00486	CcSEcCtD
Pitavastatin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00486	CcSEcCtD
Pitavastatin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00486	CcSEcCtD
Pitavastatin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00486	CcSEcCtD
Pitavastatin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00486	CcSEcCtD
Pitavastatin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00484	CcSEcCtD
Pitavastatin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000627	0.0048	CcSEcCtD
Pitavastatin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000627	0.0048	CcSEcCtD
Pitavastatin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000621	0.00476	CcSEcCtD
Pitavastatin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000621	0.00476	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000616	0.00472	CcSEcCtD
Pitavastatin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00459	CcSEcCtD
Pitavastatin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00459	CcSEcCtD
Pitavastatin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000598	0.00458	CcSEcCtD
Pitavastatin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000596	0.00456	CcSEcCtD
Pitavastatin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000592	0.00453	CcSEcCtD
Pitavastatin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000589	0.00451	CcSEcCtD
Pitavastatin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000565	0.00433	CcSEcCtD
Pitavastatin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000555	0.00425	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000554	0.00424	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000554	0.00424	CcSEcCtD
Pitavastatin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00421	CcSEcCtD
Pitavastatin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00421	CcSEcCtD
Pitavastatin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000547	0.00419	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000543	0.00416	CcSEcCtD
Pitavastatin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000539	0.00412	CcSEcCtD
Pitavastatin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.0041	CcSEcCtD
Pitavastatin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000535	0.0041	CcSEcCtD
Pitavastatin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.00408	CcSEcCtD
Pitavastatin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00405	CcSEcCtD
Pitavastatin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00401	CcSEcCtD
Pitavastatin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00401	CcSEcCtD
Pitavastatin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00401	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.00401	CcSEcCtD
Pitavastatin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00398	CcSEcCtD
Pitavastatin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00398	CcSEcCtD
Pitavastatin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00398	CcSEcCtD
Pitavastatin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000518	0.00397	CcSEcCtD
Pitavastatin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00393	CcSEcCtD
Pitavastatin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00387	CcSEcCtD
Pitavastatin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00386	CcSEcCtD
Pitavastatin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00385	CcSEcCtD
Pitavastatin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000501	0.00384	CcSEcCtD
Pitavastatin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000501	0.00384	CcSEcCtD
Pitavastatin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.00383	CcSEcCtD
Pitavastatin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00382	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00381	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00381	CcSEcCtD
Pitavastatin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00379	CcSEcCtD
Pitavastatin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00376	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00373	CcSEcCtD
Pitavastatin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000483	0.0037	CcSEcCtD
Pitavastatin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000483	0.0037	CcSEcCtD
Pitavastatin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00368	CcSEcCtD
Pitavastatin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00368	CcSEcCtD
Pitavastatin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00364	CcSEcCtD
Pitavastatin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00363	CcSEcCtD
Pitavastatin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000475	0.00363	CcSEcCtD
Pitavastatin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00362	CcSEcCtD
Pitavastatin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00362	CcSEcCtD
Pitavastatin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00361	CcSEcCtD
Pitavastatin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000471	0.00361	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.0036	CcSEcCtD
Pitavastatin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00349	CcSEcCtD
Pitavastatin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00348	CcSEcCtD
Pitavastatin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00343	CcSEcCtD
Pitavastatin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00343	CcSEcCtD
Pitavastatin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00343	CcSEcCtD
Pitavastatin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00336	CcSEcCtD
Pitavastatin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00334	CcSEcCtD
Pitavastatin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00334	CcSEcCtD
Pitavastatin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00329	CcSEcCtD
Pitavastatin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00329	CcSEcCtD
Pitavastatin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00327	CcSEcCtD
Pitavastatin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00324	CcSEcCtD
Pitavastatin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00323	CcSEcCtD
Pitavastatin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00319	CcSEcCtD
Pitavastatin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00319	CcSEcCtD
Pitavastatin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00315	CcSEcCtD
Pitavastatin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00312	CcSEcCtD
Pitavastatin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00311	CcSEcCtD
Pitavastatin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00308	CcSEcCtD
Pitavastatin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00308	CcSEcCtD
Pitavastatin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00302	CcSEcCtD
Pitavastatin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00301	CcSEcCtD
Pitavastatin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000388	0.00297	CcSEcCtD
Pitavastatin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00294	CcSEcCtD
Pitavastatin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00294	CcSEcCtD
Pitavastatin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00293	CcSEcCtD
Pitavastatin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00293	CcSEcCtD
Pitavastatin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00292	CcSEcCtD
Pitavastatin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00292	CcSEcCtD
Pitavastatin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00291	CcSEcCtD
Pitavastatin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00288	CcSEcCtD
Pitavastatin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00287	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000374	0.00287	CcSEcCtD
Pitavastatin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00286	CcSEcCtD
Pitavastatin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.00279	CcSEcCtD
Pitavastatin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00277	CcSEcCtD
Pitavastatin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00277	CcSEcCtD
Pitavastatin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00277	CcSEcCtD
Pitavastatin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00277	CcSEcCtD
Pitavastatin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00275	CcSEcCtD
Pitavastatin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00271	CcSEcCtD
Pitavastatin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00261	CcSEcCtD
Pitavastatin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000339	0.0026	CcSEcCtD
Pitavastatin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.00228	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00208	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00208	CcSEcCtD
Pitavastatin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00202	CcSEcCtD
Pitavastatin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.002	CcSEcCtD
Pitavastatin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00191	CcSEcCtD
Pitavastatin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00191	CcSEcCtD
Pitavastatin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00189	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00186	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00167	CcSEcCtD
Pitavastatin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00167	CcSEcCtD
Pitavastatin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00166	CcSEcCtD
Pitavastatin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00161	CcSEcCtD
Pitavastatin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00159	CcSEcCtD
Pitavastatin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00159	CcSEcCtD
Pitavastatin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00158	CcSEcCtD
Pitavastatin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00158	CcSEcCtD
Pitavastatin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00157	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00151	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000196	0.0015	CcSEcCtD
Pitavastatin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.0015	CcSEcCtD
Pitavastatin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00146	CcSEcCtD
Pitavastatin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00145	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00135	CcSEcCtD
Pitavastatin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00131	CcSEcCtD
Pitavastatin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000169	0.0013	CcSEcCtD
Pitavastatin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00125	CcSEcCtD
Pitavastatin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00121	CcSEcCtD
Pitavastatin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00116	CcSEcCtD
Pitavastatin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Pitavastatin—Headache—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00115	CcSEcCtD
Pitavastatin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00109	CcSEcCtD
Pitavastatin—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.95e-05	0.00122	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	8.95e-05	0.00122	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	8.94e-05	0.00122	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GC—chronic obstructive pulmonary disease	8.76e-05	0.00119	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	8.6e-05	0.00117	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.48e-05	0.00116	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.46e-05	0.00115	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.43e-05	0.00115	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.41e-05	0.00115	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.34e-05	0.00114	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.28e-05	0.00113	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.28e-05	0.00113	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	8.25e-05	0.00112	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.19e-05	0.00111	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.14e-05	0.00111	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.14e-05	0.00111	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	8.03e-05	0.00109	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	7.97e-05	0.00108	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.00108	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.85e-05	0.00107	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.77e-05	0.00106	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.76e-05	0.00106	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.68e-05	0.00105	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.67e-05	0.00104	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.65e-05	0.00104	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	7.45e-05	0.00101	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	7.31e-05	0.000996	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.27e-05	0.000991	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.2e-05	0.00098	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.15e-05	0.000974	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.12e-05	0.000969	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.11e-05	0.000969	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.11e-05	0.000969	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.05e-05	0.000961	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	7.04e-05	0.000959	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.96e-05	0.000947	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.92e-05	0.000943	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.88e-05	0.000937	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.79e-05	0.000925	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.63e-05	0.000904	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.58e-05	0.000896	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.49e-05	0.000884	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.49e-05	0.000884	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.48e-05	0.000883	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.39e-05	0.000871	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.15e-05	0.000837	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.13e-05	0.000835	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.11e-05	0.000832	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.06e-05	0.000825	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.98e-05	0.000815	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.87e-05	0.000799	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.82e-05	0.000793	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GCLC—chronic obstructive pulmonary disease	5.8e-05	0.00079	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.78e-05	0.000787	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.75e-05	0.000784	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.74e-05	0.000782	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.7e-05	0.000776	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.66e-05	0.000771	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.65e-05	0.00077	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.58e-05	0.00076	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	5.54e-05	0.000755	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.52e-05	0.000752	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.41e-05	0.000737	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.4e-05	0.000735	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CTGF—chronic obstructive pulmonary disease	5.29e-05	0.000721	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.28e-05	0.000719	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.28e-05	0.000719	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.28e-05	0.000719	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.000718	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.24e-05	0.000713	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.22e-05	0.000711	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.2e-05	0.000709	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.15e-05	0.000702	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	5.13e-05	0.000699	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.06e-05	0.000689	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.03e-05	0.000685	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5e-05	0.000681	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.99e-05	0.00068	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.94e-05	0.000673	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.000672	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.92e-05	0.00067	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.92e-05	0.000669	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.88e-05	0.000664	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.85e-05	0.00066	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.78e-05	0.000651	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.77e-05	0.00065	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.73e-05	0.000644	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.71e-05	0.000641	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.67e-05	0.000636	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.65e-05	0.000634	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.62e-05	0.000629	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.61e-05	0.000628	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.59e-05	0.000624	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.51e-05	0.000614	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.46e-05	0.000607	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.42e-05	0.000602	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.000592	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	4.32e-05	0.000588	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.31e-05	0.000587	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.29e-05	0.000584	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.26e-05	0.00058	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.19e-05	0.000571	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.15e-05	0.000566	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.11e-05	0.000559	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.09e-05	0.000557	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.07e-05	0.000554	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.07e-05	0.000554	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	4.07e-05	0.000554	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.02e-05	0.000548	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.02e-05	0.000548	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.01e-05	0.000546	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.01e-05	0.000545	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4e-05	0.000545	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.98e-05	0.000541	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.95e-05	0.000538	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.75e-05	0.00051	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.74e-05	0.000509	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.67e-05	0.0005	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.59e-05	0.000489	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.54e-05	0.000483	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.00048	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.51e-05	0.000477	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.41e-05	0.000464	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.38e-05	0.000461	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.38e-05	0.00046	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.32e-05	0.000452	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.28e-05	0.000446	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.27e-05	0.000445	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.26e-05	0.000443	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.25e-05	0.000442	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.23e-05	0.000441	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.00044	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.19e-05	0.000434	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.17e-05	0.000431	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.12e-05	0.000426	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.08e-05	0.00042	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.05e-05	0.000415	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.03e-05	0.000412	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.99e-05	0.000408	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.96e-05	0.000403	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.95e-05	0.000402	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.94e-05	0.000401	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.89e-05	0.000393	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.87e-05	0.000391	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.87e-05	0.000391	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.85e-05	0.000389	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.000385	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.83e-05	0.000385	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.82e-05	0.000384	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.8e-05	0.000382	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.79e-05	0.00038	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.78e-05	0.000379	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.78e-05	0.000378	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.77e-05	0.000378	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.73e-05	0.000372	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.000371	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000363	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.65e-05	0.000361	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.64e-05	0.00036	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.59e-05	0.000353	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.59e-05	0.000353	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.58e-05	0.000351	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.53e-05	0.000345	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.53e-05	0.000344	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.000343	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.46e-05	0.000335	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.000334	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.41e-05	0.000328	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—chronic obstructive pulmonary disease	2.41e-05	0.000328	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.36e-05	0.000321	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00032	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.34e-05	0.000319	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.33e-05	0.000317	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.31e-05	0.000315	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.31e-05	0.000314	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NOS3—chronic obstructive pulmonary disease	2.3e-05	0.000314	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.27e-05	0.000309	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.21e-05	0.000301	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.15e-05	0.000293	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.12e-05	0.000288	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.000286	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.08e-05	0.000284	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000283	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.07e-05	0.000282	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.98e-05	0.000269	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	1.96e-05	0.000267	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.94e-05	0.000265	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.000263	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.000262	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.92e-05	0.000261	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.88e-05	0.000256	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000252	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.000249	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.79e-05	0.000243	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.77e-05	0.000241	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.76e-05	0.000239	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.74e-05	0.000237	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.74e-05	0.000237	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000236	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.72e-05	0.000234	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000233	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000231	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.000228	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	1.67e-05	0.000227	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000218	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.6e-05	0.000217	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.57e-05	0.000214	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000213	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000206	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000204	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.45e-05	0.000197	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000196	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000193	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000191	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000186	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000181	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000178	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000174	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000172	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000169	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.21e-05	0.000164	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-05	0.000164	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000163	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.19e-05	0.000162	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000162	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000161	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.00016	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.15e-05	0.000157	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.11e-05	0.000151	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.11e-05	0.000151	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.00015	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.1e-05	0.00015	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000143	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000143	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000142	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000141	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.82e-06	0.000134	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.68e-06	0.000132	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.66e-06	0.000132	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.16e-06	0.000125	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	9.12e-06	0.000124	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.02e-06	0.000123	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.55e-06	0.000116	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.14e-06	9.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.83e-06	9.31e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.79e-06	9.25e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.22e-06	8.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.95e-06	8.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.81e-06	7.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.56e-06	7.57e-05	CbGpPWpGaD
